• Nenhum resultado encontrado

Top PDF Non-small cell lung cancer in never smokers: a clinical entity to be identified

Non-small cell lung cancer in never smokers: a clinical entity to be identified

Non-small cell lung cancer in never smokers: a clinical entity to be identified

... according to the Kaplan-Meier method, while a log-rank test was used to assess the differences in survival between the ...vs. non-adenocarcinoma), AJCC stage (early ...variables in the ...

5

Plasminogen Activator Inhibitor-2 Plays a Leading Prognostic Role among Protease Families in Non-Small Cell Lung Cancer.

Plasminogen Activator Inhibitor-2 Plays a Leading Prognostic Role among Protease Families in Non-Small Cell Lung Cancer.

... shown to accelerate cell migration in vitro. In comparison, our IHC data demonstrated no correlation between uPAR IHC expression level and patient ...network in vivo [31]. Although our ...

15

Association of TERT Polymorphisms with Clinical Outcome of Non-Small Cell Lung Cancer Patients.

Association of TERT Polymorphisms with Clinical Outcome of Non-Small Cell Lung Cancer Patients.

... role in cancer initia- tion and ...ations in the TERT gene as risk factors for many cancer types ...of lung cancer ...with lung cancer risk in ...

13

Exosomes isolation and characterization in serum is feasible in non-small cell lung cancer patients: critical analysis of evidence and potential role in clinical practice

Exosomes isolation and characterization in serum is feasible in non-small cell lung cancer patients: critical analysis of evidence and potential role in clinical practice

... [3] in a study to understand the biologic process underlying the differentiation of reticulocytes to mature ...with small membrane vesicles of uniform size (40-100 ...released in the ...

13

Circulating MicroRNAs as Non-Invasive Biomarkers for Early Detection of Non-Small-Cell Lung Cancer.

Circulating MicroRNAs as Non-Invasive Biomarkers for Early Detection of Non-Small-Cell Lung Cancer.

... ists in that miRNAs identified in the blood merely indicate changes in blood cells secondary to an overall poor health condition and are not specific to the presence of ...

14

Epidermal growth factor receptor (EGFR) mutations in lung cancer: preclinical and clinical data

Epidermal growth factor receptor (EGFR) mutations in lung cancer: preclinical and clinical data

... NSCLCs in patients with European or African ethnicities, 35% of NSCLCs in East Asians, and 50% of NSCLCs in never- smokers are EGFR mutation ...mutations in tumors with squamous ...

11

BRCA1: a novel prognostic factor in resected non-small-cell lung cancer.

BRCA1: a novel prognostic factor in resected non-small-cell lung cancer.

... 37 to 77 years (median age, 64 ...were smokers, 39 former smokers, and the remaining seven ...due to poor pulmonary ...according to the International System for Staging Lung ...

7

Albumin and Neutrophil Combined Prognostic Grade as a New Prognostic Factor in Non-Small Cell Lung Cancer: Results from a Large Consecutive Cohort.

Albumin and Neutrophil Combined Prognostic Grade as a New Prognostic Factor in Non-Small Cell Lung Cancer: Results from a Large Consecutive Cohort.

... using clinical cut-off determination, pretreatment albumin lost its significance on predicting outcome for NSCLC, and ANPG was also disqualified for independent prognostic factor in multivariate ...might ...

14

MicroRNA-dependent regulation of transcription in non-small cell lung cancer.

MicroRNA-dependent regulation of transcription in non-small cell lung cancer.

... participate in the regulation of almost every cellular process investigated and that changes in their expression are observed in diseases such as ...may be involved in the development ...

13

Serum levels of the cancer-testis antigen POTEE and its clinical significance in non-small-cell lung cancer.

Serum levels of the cancer-testis antigen POTEE and its clinical significance in non-small-cell lung cancer.

... expressed in many cancers and some normal reproductive tissues [16, ...roles in both physiologic and pathologic conditions, includ- ing the cytoskeletal structure [8], apoptotic pathways [11], epigenetic ...

10

Concomitant active tuberculosis prolongs survival in non-small cell lung cancer: a study in a tuberculosis-endemic country.

Concomitant active tuberculosis prolongs survival in non-small cell lung cancer: a study in a tuberculosis-endemic country.

... decreased in squamous cell carcinoma with active ...dendritic cell via a TGF-beta 1 dependent mechanism[29]. In light of this, report from MacKinnon et ...critical in building a tumor ...

7

MicroRNA expression and clinical outcome of small cell lung cancer.

MicroRNA expression and clinical outcome of small cell lung cancer.

... microRNAs in small-cell lung carcinoma (SCLC) is largely ...microRNA in many cancer ...has never been studied in SCLC, a cancer type with frequent ...

8

Polymorphisms of homologous recombination genes and clinical outcomes of non-small cell lung cancer patients treated with definitive radiotherapy.

Polymorphisms of homologous recombination genes and clinical outcomes of non-small cell lung cancer patients treated with definitive radiotherapy.

... G.C to be associated with a reduced RP incidence but a decreased ...likely to have an impact on patients’ survival ...[35]. In this study, we were much interested in the finding that ...

9

An Overview: Treatment of Lung Cancer on Researcher Point of View

An Overview: Treatment of Lung Cancer on Researcher Point of View

... ung cancer leads to death including both man & woman .In diagnostic view PET is a quantitative positron imaging technique which is helpful in early diagnosis of lung cancer ...

7

Inglês Jornal Brasileiro de Pneumologia complete v42n5 EN

Inglês Jornal Brasileiro de Pneumologia complete v42n5 EN

... Objective: Lung cancer is a global public health problem and is associated with high ...mortality. Lung cancer could be largely avoided by reducing the prevalence of ...was to ...

102

J. bras. pneumol.  vol.34 número3 en v34n3a01

J. bras. pneumol. vol.34 número3 en v34n3a01

... is to identify isolated malignant cells or even minimal clusters of these cells in histological sections routinely stained with ...lead to false-negative results. In an attempt to ...

2

PDF EN Jornal Brasileiro de Pneumologia 3 1 english

PDF EN Jornal Brasileiro de Pneumologia 3 1 english

... Dissemination to locoregional lymph nodes is a deter- mining factor in the prognosis of lung ...I non-small cell lung cancer (NSCLC) and undetected lymph node ...

2

Quantification of cell-free mSHOX2 Plasma DNA for therapy monitoring in advanced stage non-small cell (NSCLC) and small-cell lung cancer (SCLC) patients.

Quantification of cell-free mSHOX2 Plasma DNA for therapy monitoring in advanced stage non-small cell (NSCLC) and small-cell lung cancer (SCLC) patients.

... pears to be useful for the monitoring of a treatment response for advanced stage lung cancer ...of cell-free DNA is rather high as the half-life of extracellular nu- cleic acids was ...

10

Rev. Hosp. Clin.  vol.56 número2

Rev. Hosp. Clin. vol.56 número2

... with non-small cell lung cancer (NSCLC), the prospect of long-term survival is directly related to the surgical resectability of the primary ...of clinical tri- als ...

6

Rev. bras. epidemiol.  vol.17 número4

Rev. bras. epidemiol. vol.17 número4

... of lung cancer, except non-melanoma skin cancer and cervical cancer with more than three years of ...for lung cancer at other institutions (public or ...used in the ...

14

Show all 10000 documents...